Genetics of biliary lithiasis from an ethnic perspective

Clinics and Research in Hepatology and Gastroenterology

Volumn 37, Issue 2, 2013, Pages 119-125

  Krawczyk, Marcin ^a   Miquel, Juan Francisco ^b   Stokes, Caroline S ^a   Zuniga, Silvia ^a   Hampe, Jochen ^c   Mittal, Balraj ^d   Lammert, Frank ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c UNIVERSITY OF KIEL   (Germany)

^d SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CHOLESTEROL 7ALPHA MONOOXYGENASE; FARNESOID X RECEPTOR; GLUCURONOSYLTRANSFERASE 1A1;

ASIAN; CHOLESTEROL STONE; DISEASE PREDISPOSITION; ETHNICITY; EUROPEAN AMERICAN; GAIN OF FUNCTION MUTATION; GALLSTONE; GENE FLOW; GENE FREQUENCY; GENE INTERACTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HISPANIC; HOMOZYGOSITY; HUMAN; INDEL MUTATION; INDIAN; SHORT SURVEY; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH AMERICA;

ATP-BINDING CASSETTE TRANSPORTERS; CENTRAL AMERICA; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; EUROPE; GALLSTONES; GENETIC PREDISPOSITION TO DISEASE; GLUCURONOSYLTRANSFERASE; HUMANS; INDIA; LIPOPROTEINS; ORGANIC ANION TRANSPORTERS, SODIUM-DEPENDENT; POLYMORPHISM, GENETIC; SEX FACTORS; SOUTH AMERICA; SYMPORTERS;

EID: 84876709432     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2012.09.002     Document Type: Short Survey

References (64)

1. Lammert F., Miquel J.F. Gallstone disease: from genes to evidence-based therapy. J Hepatol 2008, (48 Suppl. 1):S124-S135.
2. Portincasa P., Moschetta A., Palasciano G. Cholesterol gallstone disease. Lancet 2006, 368:230-323.
3. Krawczyk M, Lammert F. Gallstone disease. www.easl.ch/iLiver 2012.
4. Mendez-Sanchez N., Zamora-Valdes D., Chavez-Tapia N.C., Uribe M. Role of diet in cholesterol gallstone formation. Clin Chim Acta 2007, 376:1-8.
5. Stokes C.S., Krawczyk M., Lammert F. Gallstones: environment, lifestyle and genes. Dig Dis 2011, 29:191-201.
6. Krawczyk M., Wang D.Q., Portincasa P., Lammert F. Dissecting the genetic heterogeneity of gallbladder stone formation. Semin Liver Dis 2011, 31:157-172.
7. Wittenburg H., Lammert F. Genetic predisposition to gallbladder stones. Semin Liver Dis 2007, 27:109-121.
8. Rosmorduc O., Hermelin B., Poupon R. MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis. Gastroenterology 2001, 120:1459-1467.
9. Rosmorduc O., Hermelin B., Boelle P.Y., Parc R., Taboury J., Poupon R. ABCB4 gene mutation-associated cholelithiasis in adults. Gastroenterology 2003, 125:452-459.
10. Katsika D., Grjibovski A., Einarsson C., Lammert F., Lichtenstein P., Marschall H.U. Genetic and environmental influences on symptomatic gallstone disease: a Swedish study of 43,141 twin pairs. Hepatology 2005, 41:1138-1143.
11. Buch S., Schafmayer C., Völzke H., Seeger M., Miquel J.F., Sookoian S.C., et al. Loci from a genome-wide analysis of bilirubin levels are associated with gallstone risk and composition. Gastroenterology 2010, 139:1942-1951.e2.
12. Buch S., Schafmayer C., Völzke H., Becker C., Franke A., von Eller-Eberstein H., et al. A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease. Nat Genet 2007, 39:995-999.
13. Gylling H., Hallikainen M., Pihlajamaki J., Agren J., Laakso M., Rajaratnam R.A., et al. Polymorphisms in the ABCG5 and ABCG8 genes associate with cholesterol absorption and insulin sensitivity. J Lipid Res 2004, 45:1660-1665.
14. Acalovschi M., Ciocan A., Mostean O., Tirziu S., Chiorean E., Keppeler H., et al. Are plasma lipid levels related to ABCG5/ABCG8 polymorphisms? A preliminary study in siblings with gallstones. Eur J Intern Med 2006, 17:490-494.
15. Krawczyk M., Lütjohann D., Schirin-Sokhan R., Villarroel L., Nervi F., Pimentel F., et al. Phytosterol and cholesterol precursor levels indicate increased cholesterol excretion and biosynthesis in gallstone patients. Hepatology 2012, 55:1507-1517.
16. Grünhage F., Acalovschi M., Tirziu S., Walier M., Wienker T.F., Ciocan A., et al. Increased gallstone risk in humans conferred by common variant of hepatic ATP-binding cassette transporter for cholesterol. Hepatology 2007, 46:793-801.
17. Katsika D., Magnusson P., Krawczyk M., Grünhage F., Lichtenstein P., Einarsson C., et al. Gallstone disease in Swedish twins: risk is associated with ABCG8 D19H genotype. J Intern Med 2010, 268:279-285.
18. Stender S., Frikke-Schmidt R., Nordestgaard B.G., Tybjaerg-Hansen A. Sterol transporter adenosine triphosphate-binding cassette transporter G8, gallstones, and biliary cancer in 62,000 individuals from the general population. Hepatology 2010, 53:640-648.
19. Duvaldestin P., Mahu J.L., Metreau J.M., Arondel J., Preaux A.M., Berthelot P. Possible role of a defect in hepatic bilirubin glucuronidation in the initiation of cholesterol gallstones. Gut 1980, 21:650-655.
20. Ostrow J.D. Unconjugated bilirubin and cholesterol gallstone formation. Hepatology 1990, 12:219S-224S.
21. Johnson A.D., Kavousi M., Smith A.V., Chen M.H., Dehghan A., Aspelund T., et al. Genome-wide association meta-analysis for total serum bilirubin levels. Hum Mol Genet 2009, 18:2700-2710.
22. Lin J.P., Schwaiger J.P., Cupples L.A., O'Donnell C.J., Zheng G., Schoenborn V., et al. Conditional linkage and genome-wide association studies identify UGT1A1 as a major gene for anti-atherogenic serum bilirubin levels--the Framingham Heart Study. Atherosclerosis 2009, 206:228-233.
23. Sanna S., Busonero F., Maschio A., McArdle P.F., Usala G., Dei M., et al. Common variants in the SLCO1B3 locus are associated with bilirubin levels and unconjugated hyperbilirubinemia. Hum Mol Genet 2009, 18:2711-2718.
24. Stender S., Frikke-Schmidt R., Nordestgaard B.G., Tybjaerg-Hansen A. Genetic variation in UGT1A1 and ABCG8 D19H associatewith stepwise increases in risk of gallstone disease in 62,381 individuals from the general population. Hepatology 2011, 54:725A.
25. Tsezou A., Tzetis M., Giannatou E., Spanos I., Roma E., Fretzayas A., et al. Gilbert syndrome as a predisposing factor for cholelithiasis risk in the Greek adult population. Genet Test Mol Biomarkers 2009, 13:143-146.
26. Renner O., Harsch S., Schaeffeler E., Winter S., Schwab M., Krawczyk M., et al. A variant of the SLC10A2 gene encoding the apical sodium-dependent bile acid transporter is a risk factor for gallstone disease. PLoS One 2009, 4:e7321.
27. Kovacs P., Kress R., Rocha J., Kurtz U., Miquel J.F., Nervi F., et al. Variation of the gene encoding the nuclear bile salt receptor FXR and gallstone susceptibility in mice and humans. J Hepatol 2008, 48:116-124.
28. Tonjes A., Wittenburg H., Halbritter J., Renner O., Harsch S., Stange E.F., et al. Effects of SLC10A2 variant rs9514089 on gallstone risk and serum cholesterol level- meta-analysis of three independent cohorts. BMC Med Genet 2011, 12:149.
29. Carey M.C., Paigen B. Epidemiology of the American Indians' burden and its likely genetic origins. Hepatology 2002, 36:781-791.
30. Nervi F., Miquel J.F., Marshall G. The Amerindian epidemics of cholesterol gallstones: the North and South connection. Hepatology 2003, 37:947-978.
31. Everhart J.E., Yeh F., Lee E.T., Hill M.C., Fabsitz R., Howard B.V., et al. Prevalence of gallbladder disease in American Indian populations: findings from the Strong Heart Study. Hepatology 2002, 35:1507-1512.
32. Munizaga J., Allison M.J., Paredes C. Cholelithiasis and cholecystitis in pre-Columbian Chileans. Am J Phys Anthropol 1978, 48:209-223.
33. Reich D., Patterson N., Campbell D., Tandon A., Mazieres S., Ray N., et al. Reconstructing Native American population history. Nature 2012, 488:370-374.
34. Everhart J.E., Khare M., Hill M., Maurer K.R. Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology 1999, 117:632-639.
35. Maurer K.R., Everhart J.E., Ezzati T.M., Johannes R.S., Knowler W.C., Larson D.L., et al. Prevalence of gallstone disease in Hispanic populations in the United States. Gastroenterology 1989, 96:487-492.
36. Miquel J.F., Covarrubias C., Villaroel L., Mingrone G., Greco A.V., Puglielli L., et al. Genetic epidemiology of cholesterol cholelithiasis among Chilean Hispanics, Amerindians, and Maoris. Gastroenterology 1998, 115:937-946.
37. Stinton L.M., Shaffer E.A. Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut Liver 2012, 6:172-187.
38. Developing genetics for developing countries. Nat Genet 2007; 39:1287.
39. Duggirala R., Mitchell B.D., Blangero J., Stern M.P. Genetic determinants of variation in gallbladder disease in the Mexican-American population. Genet Epidemiol 1999, 16:191-204.
40. Puppala S., Dodd G.D., Fowler S., Arya R., Schneider J., Farook V.S., et al. A genomewide search finds major susceptibility loci for gallbladder disease on chromosome 1 in Mexican Americans. Am J Hum Genet 2006, 78:377-392.
41. Nervi F. Cancer of the gallbladder in Chile. Rev Med Chil 2001, 129:979-981.
42. Perez-Ayuso R.M., Hernandez V., Gonzalez B., Carvacho C., Navarrete C., Alvarez M., et al. Natural history of cholelithiasis and incidence of cholecystectomy in an urban and a Mapuche rural area. Rev Med Chil 2002, 130:723-730.
43. Mella J.G., Schirin-Sokhan R., Rigotti A., Pimentel F., Villarroel L., Wasmuth H.E., et al. Genetic evidence that apolipoprotein E4 is not a relevant susceptibility factor for cholelithiasis in two high-risk populations. J Lipid Res 2007, 48:1378-1385.
44. Sanchez-Cuen J., Aguilar-Medina M., Arambula-Meraz E., Romero-Navarro J., Granados J., Sicairos-Medina L., et al. ApoB-100, ApoE and CYP7A1 gene polymorphisms in Mexican patients with cholesterol gallstone disease. World J Gastroenterol 2010, 16:4685-4690.
45. Khuroo M.S., Mahajan R., Zargar S.A., Javid G., Sapru S. Prevalence of biliary tract disease in India: a sonographic study in adult population in Kashmir. Gut 1989, 30:201-205.
46. Kotwal M.R., Rinchen C.Z. Gallstone disease in the Himalayas (Sikkim and north Bengal): causation and stone analysis. Indian J Gastroenterol 1998, 17:87-89.
47. Ananthkrishnan N. Current concepts in the pathogenesis of gallstones. Indian Jour Sur 1998, 60:85-89.
48. Tyagi B.B., Manoharan N., Raina V. Risk factors for gallbladder cancer: a population-based case-control study in Delhi. Indian J Med Paediat Oncol 2008, 29:16-26.
49. Dixit M., Choudhuri G., Keshri L.J., Mittal B. Association of low density lipoprotein receptor related protein-associated protein (LRPAP1) gene insertion/deletion polymorphism with gallstone disease. J Gastroenterol Hepatol 2006, 21:847-849.
50. Dixit M., Choudhuri G., Saxena R., Mittal B. Association of apolipoprotein A1-C3 gene cluster polymorphisms with gallstone disease. Can J Gastroenterol 2007, 21:569-575.
51. Dixit M., Bhattacharya S., Mittal B. Association of CETP TaqI and APOE polymorphisms with type II diabetes mellitus in North Indians: a case control study. BMC Endocr Disord 2005, 5:7.
52. Srivastava A., Srivastava N., Choudhuri G., Mittal B. Organic anion transporter 1B1 (SLCO1B1) polymorphism and gallstone formation: high incidence of Exon4 CA genotype in female patients in North India. Hepatol Res 2011, 41:71-78.
53. Hu M., Tomlinson B. Effects of statin treatments and polymorphisms in UGT1A1 and SLCO1B1 on serum bilirubin levels in Chinese patients with hypercholesterolaemia. Atherosclerosis 2012, 223:427-432.
54. Srivastava A., Srivastava K., Choudhuri G., Mittal B. Role of ABCG8 D19H (rs11887534) variant in gallstone susceptibility in northern India. J Gastroenterol Hepatol 2010, 25:1758-1762.
55. Siddapuram S.P., Mahurkar S., Duvvuru N.R., Mitnala S., Guduru V.R., Rebala P., et al. Hepatic cholesterol transporter ABCG8 polymorphisms in gallstone disease in an Indian population. J Gastroenterol Hepatol 2010, 25:1093-1098.
56. Kuo K.K., Shin S.J., Chen Z.C., Yang Y.H., Yang J.F., Hsiao P.J. Significant association of ABCG5 604Q and ABCG8 D19H polymorphisms with gallstone disease. Br J Surg 2008, 95:1005-1011.
57. Srivastava A., Pandey S.N., Choudhuri G., Mittal B. Role of genetic variant A-204C of cholesterol 7alpha-hydroxylase (CYP7A1) in susceptibility to gallbladder cancer. Mol Genet Metab 2008, 94:83-89.
58. Pullinger C.R., Eng C., Salen G., Shefer S., Batta A.K., Erickson S.K., et al. Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype. J Clin Invest 2002, 110:109-117.
59. Pullinger C.R., Eng C., Malloy M.J., Kane J.P. Cholesterol 7alpha-hydroxylase (CYP7A1) gene mutation: another cause for gallstone formation?. Gallstones: pathogenesis and treatment 2004, Kluwer Academics Publishers, Dordrecht/Boston/London. G. Adler, H.E. Blum, M. Fuchs, E.F. Stange (Eds.).
60. Miyake J.H., Duong-Polk X.T., Taylor J.M., Du E.Z., Castellani L.W., Lusis A.J., et al. Transgenic expression of cholesterol-7-alpha-hydroxylase prevents atherosclerosis in C57BL/6J mice. Arterioscler Thromb Vasc Biol 2002, 22:121-126.
61. Srivastava A., Sharma K.L., Srivastava N., Misra S., Mittal B. Significant role of estrogen and progesterone receptor sequence variants in gallbladder cancer predisposition: a multi-analytical strategy. PLoS One 2012, 7:e40162.
62. Tennessen J.A., Bigham A.W., O'Connor T.D., Fu W., Kenny E.E., Gravel S., et al. Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science 2012, 337:64-69.
63. Chiang C.W., Gajdos Z.K., Korn J.M., Kuruvilla F.G., Butler J.L., Hackett R., et al. Rapid assessment of genetic ancestry in populations of unknown origin by genome-wide genotyping of pooled samples. PLoS Genet 2010, 6:e1000866.
64. Krawczyk M., Müllenbach R., Weber S.N., Zimmer V., Lammert F. Genome-wide association studies and genetic risk assessment of liver diseases. Nat Rev Gastroenterol Hepatol 2010, 7:669-681.